Affiliations: [a] State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products, Ningbo University, Ningbo, China
| [b]
Collaborative Innovation Center for Zhejiang Marine High-efficiency and Healthy Aquaculture, Ningbo University, Ningbo, Zhejiang, China
| [c]
Department of Laboratory Medicine, Ningbo Medical Centre Lihuili Hospital, Ningbo University, Ningbo, China
| [d]
Ningbo Kangning Hospital, Ningbo Key Laboratory of Sleep Medicine, Ningbo, China
Correspondence:
[*]
Correspondence to: Wei Wu and Haimin Chen, State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products, Ningbo University, Ningbo, Zhejiang 315211, China. Tel.: +86 574 87609575; Fax: +86 574 87609575; E-mail: wuwei@nbu.edu.cn. (Wu); E-mail: chenhaimin@nbu.edu.cn. (Chen)
Abstract: Background:Serum homocysteine (Hcy) level is considered to be an important biomarker for Alzheimer’s disease (AD); however, the status of Hcy in brain tissue, and the association between brain and serum levels of Hcy in AD patients remain unclear. Objective:We aimed to examine whether the changes of three thiols are consistent in serum of AD patients and the brain of APP/PS1 mice, and to verify the effectiveness of Hcy as a biomarker for early AD detection. Methods:The levels of Hcy, cysteine (Cys), and glutathione (GSH) in Aβ1–42-treated PC12 cells, the brain and hippocampus of APP/PS1 mouse, and the serum of AD patients were evaluated using ethyl (E)-3-(9-chloro-11-oxo-2,3,6,7-tetrahydro-1H,5H,11H-pyrano[2,3-f] pyrido [3,2,1 -ij] quinolin-10-yl)-2-cyanoacrylate (Probe 1) and ELISA assay or LC-MS. Results:Measurement by Probe 1 revealed a significant increase in Hcy level, and a decrease in Cys and GSH levels in Aβ1–42-treated PC12 cells and the serum of AD patients. The hippocampus and whole brain of APP/PS1 mice also showed a significant increase in Hcy level alongside the accumulation of age-related AD symptoms. The upregulation of Hcy and the downregulation of Cys and GSH were reversed in the Aβ1–42-treated PC12 cells and the brain of APP/PS1 mice when supplemented with VB6. Conclusion:Changes in Hcy, Cys, and GSH levels in the brain of APP/PS1 mice and Aβ1–42-treated PC12 cells were observed in situ with a new fluorescent probe, which were consistent with the abnormal changes in Hcy, Cys, and GSH levels in the serum of AD patients. VB6 supplementation was successful in ameliorating abnormal increases in Hcy levels.
